Mayo Clinic researchers have demonstrated in two new studies that availability of data supporting testosterone?s efficacy in treating sexual dysfunction and its cardiovascular safety, is very limited.
In their article, published in the journal Mayo Clinic Proceedings, they call for large studies to help clinicians and patients make informed decisions about when testosterone should be prescribed.
“One of the initial surprises is how limited the research evidence is regarding whether testosterone is an effective treatment for sexual dysfunction while being safe from the cardiovascular disease standpoint,” says lead researcher Dr. Victor M. Montori, Mayo Clinic`s Knowledge and Encounter Research Unit. “There is no way for physicians to be certain when prescribing testosterone that, on average, it`s doing more good than harm,” he added.
The two studies conducted by the researchers were based on the review and meta-analysis of randomised trials to assess the effect of testosterone on sexual dysfunction and cardiovascular events.